Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin ER/Lovastatin vs Usual Care for Dyslipidemia (EXTEND)
NCT00345657Phase 4Completed
- Sponsor
- In His Image
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of niacin and lovastatin in dyslipidemia, sponsored by In His Image. Primary endpoints: Lipid parameter change at 6 months and Percent of patients achieving ATP III LDL goals at 6 months. Started Jul 2003; status: completed.
02
Drugs
niacinlovastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00345657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345657.